The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
Open accessAbstract
In patients with Parkinson's disease (PD), the associated pathology follows a characteristic pattern involving inter alia the enteric nervous system (ENS), the dorsal motor nucleus of the vagus (DMV), the intermediolateral nucleus of the spinal cord and the substantia nigra, providing the basis for the neuropathological staging of the disease. Here we report that intragastrically administered rotenone, a commonly used pesticide that inhibits Complex I of the mitochondrial respiratory chain, is able to reproduce PD pathological staging as found in patients. Our results show that low doses of chronically and intragastrically administered rotenone induce alpha-synuclein accumulation in all the above-mentioned nervous system structures of wild-type mice. Moreover, we also observed inflammation and alpha-synuclein phosphorylation in the ENS and DMV. HPLC analysis showed no rotenone levels in the systemic blood or the central nervous system (detection limit [rotenone]<20 nM) and mitochondrial Complex I measurements showed no systemic Complex I inhibition after 1.5 months of treatment. These alterations are sequential, appearing only in synaptically connected nervous structures, treatment time-dependent and accompanied by inflammatory signs and motor dysfunctions. These results strongly suggest that the local effect of pesticides on the ENS might be sufficient to induce PD-like progression and to reproduce the neuroanatomical and neurochemical features of PD staging. It provides new insight into how environmental factors could trigger PD and suggests a transsynaptic mechanism by which PD might spread throughout the central nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rotenone (a pesticide) administered intragastrically in mice (5 mg/kg, 5 days a week, up to 3 months) induced accumulation of α-synuclein in several structures of the nervous system (i.e., dorsal motor nucleus of the vagus, intermediolateral nucleus of the spinal cord, the substantia nigra) along with inflammation and α-synuclein phosphorylation in the ENS and the dorsal motor nucleus of the vagus”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [405]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Self-citationMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
GUNDERSEN, H. J. G., BENDTSEN, T. F., KORBO, L., MARCUSSEN, N., MØLLER, A., NIELSEN, K., NYENGAARD, J. R., PAKKENBERG, B., SØRENSEN, F. B., VESTERBY, A., et al. (1988) · APMIS · doi:10.1111/j.1699-0463.1988.tb05320.x · Cited by 2,929
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán‐Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munaín, A. L., Aparicio, S. F., Gil, A. M., Khan, N. L., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,453
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,174
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 524
Garrido‐Gil, P., Rodriguez-Perez, A. I., Dominguez‐Meijide, A., Guerra, M. J., & Labandeira-García, J. L. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0937-8 · Cited by 114
α‐Synuclein: The Long Distance Runner
George, S., Rey, N. L., Reichenbach, N., Steiner, J. A., & Brundin, P. (2013) · Brain Pathology · doi:10.1111/bpa.12046 · Cited by 114
Hu, Q. Z., Uversky, V. N., Huang, M., Kang, H., Xu, F., Liu, X., Lian, L., Liang, Q., Jiang, H., Liu, A., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.008 · Cited by 109
Self-citationThe Search for Environmental Causes of Parkinson’s Disease: Moving Forward
Chen, H., & Ritz, B. R. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181493 · Cited by 113
Animal Models of Parkinson's Disease: A Gateway to Therapeutics?
Le, W., Sayana, P., & Jankovic, J. J. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0234-1 · Cited by 114
Hu, B., Das, P., Lv, X., Shi, M., Aa, J., Wang, K., Duan, L., Gilbert, J. A., Nie, Y., & Wu, X. (2022) · mSystems · doi:10.1128/msystems.00218-22 · Cited by 116
Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
Chiang, H., & Lin, C. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.18067 · Cited by 107
Lateralisation in Parkinson disease
Riederer, P. F., Jellinger, K. A., Kolber, P. L., Hipp, G., Sian‐Hülsmann, J., & Krüger, R. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2832-z · Cited by 107
Morshedi, D., Aliakbari, F., Marvian, A. T., Fassihi, A., Pan-Montojo, F. J., & Pérez‐Sánchez, H. (2015) · Journal of Food Science · doi:10.1111/1750-3841.13016 · Cited by 106
Self-citationGut bacterial composition in a mouse model of Parkinson’s disease
Perez-Pardo, P., Dodiya, H. B., Engen, P. A., Naqib, A., Forsyth, C. B., Green, S. J., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0202 · Cited by 102
Xiong, N., Huang, J., Chen, C., Zhao, Y. Y., Zhang, Z., Jia, M., Zhang, Z., Hou, L., Yang, H., Cao, X., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.007 · Cited by 99
Miyazaki, I., Isooka, N., Imafuku, F., Sun, J. Y., Kikuoka, R., Furukawa, C., & Asanuma, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093254 · Cited by 100
Cabezas, R., El-Bachá, R. D. S., González, J., & Barreto, G. E. (2012) · Neuroscience Research · doi:10.1016/j.neures.2012.07.008 · Cited by 98
Oro-Pharyngeal Dysphagia in Parkinson’s Disease and Related Movement Disorders
Kwon, M., & Lee, J. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.19048 · Cited by 96
Chen, Y., Zhang, D.-Q., Liao, Z., Wang, B., Gong, S., Wang, C., Zhang, M.-Z., Wang, G., Cai, H., Liao, F., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/1750-1326-10-4 · Cited by 93
Paul, R. K., Choudhury, A., Kumar, S., Giri, A., Sandhir, R., & Borah, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171285 · Cited by 93
Anticancer Drugs Targeting the Mitochondrial Electron Transport Chain
Rohlena, J., Dong, L.-F., Ralph, S. J., & Neuzil, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3990 · Cited by 91
Age-related diseases as vicious cycles
Belikov, A. V. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.002 · Cited by 95
Effects of oral administration of rotenone on gastrointestinal functions in mice
Tasselli, M., Chaumette, T., Paillusson, S., Monnet, Y., Lafoux, A., Huchet, C., Aubert, P., Hunot, S., Derkinderen, P., & Neunlist, M. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12070 · Cited by 89
Aguirre, P., Urrutia, P. J., Tapia, V., Villa, M., Paris, I. B., Segura‐Aguilar, J., & Núñez, M. T. (2012) · BioMetals · doi:10.1007/s10534-012-9525-y · Cited by 89
The Nonmotor Features of Parkinson's Disease
Titova, N., Qamar, M. A., & Chaudhuri, К. R. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.02.016 · Cited by 88
Alpha-Synuclein in Peripheral Tissues in Parkinson’s Disease
Ma, L., Liu, G.-L., Wang, D., Zhang, M., Kou, W., & Feng, T. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00383 · Cited by 87
Gastrointestinal Dysfunction in Parkinson’s Disease
Skjærbæk, C., Knudsen, K., Horsager, J., & Borghammer, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030493 · Cited by 87
Rota, L., Pellegrini, C., Benvenuti, L., Antonioli, L., Fornai, M., Blandizzi, C., Cattaneo, A., & Colla, E. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0146-z · Cited by 87
Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological Implications
Chen, H., Burton, E. A., Ross, G. W., Huang, X., Savica, R., Abbott, R. D., Ascherio, A., Caviness, J. N., Gao, X., Gray, K. A., et al. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1306967 · Cited by 83
“…showed that intra gastric rotenone caused α -synuclein aggregation in mice, following a staged pattern that was consistent with the Braak hypothesis (Pan-Montojo and Funk 2010; Pan-Montojo et al. 2010), and resection of the autonomic nerves prevented this progression (Pan-Montojo et al. 2012).”
ResultThe gut-brain axis and Parkinson disease: Clinical and pathogenetic relevance
Menozzi, E., Macnaughtan, J., & Schapira, A. H. V. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1890330 · Cited by 81
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease
Hansen, C., & Li, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.002 · Cited by 85
Milanese, C., Bombardieri, C. R., Sepe, S., Barnhoorn, S., Payán‐Gómez, C., Caruso, D., Audano, M., Pedretti, S., Vermeij, W. P., Brandt, R. M. C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12640-5 · Cited by 82
Rocha, S. M., Bantle, C. M., Aboellail, T., Chatterjee, D., Smeyne, R. J., & Tjalkens, R. B. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105685 · Cited by 87
Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model
Colucci, M., Cervio, M., Faniglione, M., Angelis, S. D., Pajoro, M., Levandis, G., Tassorelli, C., Blandini, F., Feletti, F., GIORGIO, R. D., et al. (2012) · Autonomic Neuroscience · doi:10.1016/j.autneu.2012.04.005 · Cited by 86
Generation of Ferric Iron Links Oxidative Stress to α-Synuclein Oligomer Formation
Levin, J., Högen, T., Hillmer, A. S., Bader, B., Schmidt, F., Kamp, F., Kretzschmar, H. A., Bötzel, K., & Giese, A. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11040 · Cited by 80
Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg?
Salat-Foix, D., Tran, K., Ranawaya, R., Meddings, J., & Suchowersky, O. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013202 · Cited by 80
Microbiome, Parkinson’s Disease and Molecular Mimicry
Miraglia, F., & Colla, E. (2019) · Cells · doi:10.3390/cells8030222 · Cited by 84
Moretto, A., & Colosio, C. (2012) · Toxicology · doi:10.1016/j.tox.2012.11.021 · Cited by 77
Esophageal dysfunction in different stages of Parkinson's disease
Suttrup, I., Suttrup, J., Suntrup‐Krueger, S., Siemer, M., Bauer, J., Hamacher, C., Oelenberg, S., Domagk, D., Dziewas, R., & Warnecke, T. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12915 · Cited by 80
Animal models of brain-first and body-first Parkinson's disease
Berge, N. V. D., & Ulusoy, A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105599 · Cited by 80
Sumikura, H., Takao, M., Hatsuta, H., Ito, S., Nakano, Y., Uchino, A., Nogami, A., Saito, Y., Mochizuki, H., & Murayama, S. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0236-9 · Cited by 74
Premotor Diagnosis of Parkinson’s Disease
Reichmann, H. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0159-5 · Cited by 80
Self-citationMorais, L. H., Hara, D. B., Bicca, M. A., Poli, A., & Takahashi, R. N. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000389 · Cited by 58
Lin, T., Cheng, C.-H., Chen, S., Liou, C., Huang, C., & Chuang, Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078722 · Cited by 71
Wang, H., Chen, G., Ahn, E. H., Xia, Y., Kang, S. S., Liu, X., Liu, C., Han, M.-H., Chen, S., & Ye, K. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-022-00430-8 · Cited by 71
Inflammation and neurodegeneration: the story ‘retolled’
Drouin‐Ouellet, J., & Cicchetti, F. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.07.002 · Cited by 71
Environment-contact administration of rotenone: A new rodent model of Parkinson’s disease
Liu, Y., Sun, J., Song, L.-K., Li, J., Chu, S., Yuan, Y., & Chen, N. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.058 · Cited by 69
Cansız, D., Ünal, İ., Üstündağ, Ü. V., Alturfan, A. A., Altinoz, M. A., Elmacı, İ., & Emekli‐Alturfan, E. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06532-5 · Cited by 69
The pathomechanisms underlying Parkinson's disease
Jellinger, K. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.877842 · Cited by 74
Armentero, M., Cerri, S., & Blandini, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00232 · Cited by 75
Riederer, P. F., Nagatsu, T., Youdim, M. B. H., Wulf, M., Dijkstra, J. M., & Sian‐Hülsmann, J. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02630-9 · Cited by 71
View point: Etiology in Parkinson's disease. Dual hit or spreading intoxication
Reichmann, H. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.016 · Cited by 68
Self-citationRey, N. L., George, S., & Brundin, P. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12299 · Cited by 67
Harischandra, D. S., Ghaisas, S., Rokad, D., & Kanthasamy, A. G. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx074 · Cited by 67
Respiratory disorders of Parkinson’s disease
Aquino, Y. C., Cabral, L. M., Miranda, N. C., Naccarato, M. C., Falquetto, B., Moreira, T. S., & Takakura, A. C. T. (2021) · Journal of Neurophysiology · doi:10.1152/jn.00363.2021 · Cited by 69
Chang, C. Y., Choi, D., Lee, D., Hong, Y. J., & Park, E. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060654 · Cited by 65
Ottolini, D., Calí, T., Szabó, I., & Brini, M. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0201 · Cited by 65
Cabezas, R., Báez-Jurado, E., Hidalgo‐Lanussa, O., Echeverrı́a, V., Ashrad, G. M., Sahebkar, A., & Barreto, G. E. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1203-9 · Cited by 65
In vivo, in vitro and pharmacologic models of Parkinson's disease
Salari, S., & Bagheri, M. (2019) · Physiological Research · doi:10.33549/physiolres.933895 · Cited by 64
The gut in Parkinson’s disease: Bottom‐up, top‐down, or neither?
Leclair‐Visonneau, L., Neunlist, M., Derkinderen, P., & Lebouvier, T. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13777 · Cited by 71
Are rodent models of Parkinson’s disease behaving as they should?
Vingill, S., Connor‐Robson, N., & Wade‐Martins, R. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.021 · Cited by 63
Atone, J., Wagner, K. M., Hashimoto, K., & Hammock, B. D. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106385 · Cited by 61
Parkhe, A., Parekh, P., Nalla, L. V., Sharma, N., Sharma, M., Gadepalli, A., Kate, A. S., & Khairnar, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134652 · Cited by 61
Appendectomy in mid and later life and risk of Parkinson's disease: A population‐based study
Marras, C., Lang, A. E., Austin, P. C., Lau, C., & Urbach, D. R. (2016) · Movement Disorders · doi:10.1002/mds.26670 · Cited by 60
The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues
Škorvánek, M., & Bhatia, K. P. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12425 · Cited by 62
G ut F eelings Ab out α‐ S ynuclein in G astrointestinal B iopsies: B iomarker in the M aking?
Ruffmann, C., & Parkkinen, L. (2016) · Movement Disorders · doi:10.1002/mds.26480 · Cited by 60
Parkinson’s disease as a multisystem disorder
Klingelhoefer, L., & Reichmann, H. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1692-0 · Cited by 63
Self-citationAre We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
Alfonsetti, M., Castelli, V., & d’Angelo, M. (2022) · Nutrients · doi:10.3390/nu14020380 · Cited by 61
Chorfa, A., Bétemps, D., Morignat, E., Lazizzera, C., Hogeveen, K. N., Andrieu, T., & Baron, T. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft076 · Cited by 57
Martinez, E. M., Young, A. L., Patankar, Y. R., Berwin, B. L., Wang, L., von Herrmann, K. M., Weier, J. M., & Havrda, M. C. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx117 · Cited by 59
Liu, C., Liu, Z., Zhang, Z., Li, Y., Fang, R., Li, F., & Zhang, J. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00091 · Cited by 56
Kaur, G., Behl, T., BUNGAU, S. G., Kumar, A., Uddin, M. S., Mehta, V., Zengin, G., Mathew, B., Shah, M. A., & Arora, S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200606233050 · Cited by 57
Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
Gadhe, L. G., Sakunthala, A., Mukherjee, S., Gahlot, N., Bera, R., Sawner, A. S., Kadu, P., & Maji, S. K. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106736 · Cited by 56
Fornai, M., Pellegrini, C., Antonioli, L., Segnani, C., Ippolito, C., Barocelli, E., Ballabeni, V., Vegezzi, G., Harraq, Z. A., Blandini, F., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.228510 · Cited by 56
Zhang, Q., Chen, S., Yu, S., Qin, J., Zhang, J., Cheng, Q., Ke, K., & Ding, F. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.025 · Cited by 56
Sheng, L., Stewart, T., Yang, D., Thorland, E., Soltys, D., Aro, P., Khrisat, T., Xie, Z., Li, N., Liu, Z., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00983-w · Cited by 56
Kanthasamy, A., Jin, H., Charli, A., Anantharam, V., & Kanthasamy, A. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.01.001 · Cited by 57
Accumulation of α-Synuclein Triggered by Presynaptic Dysfunction
Nakata, Y., Yasuda, T., Fukaya, M., Yamamori, S., Itakura, M., Nihira, T., Hayakawa, H., Kawanami, A., Kataoka, M., Nagai, M., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2220-12.2012 · Cited by 55
The Gut and Nonmotor Symptoms in Parkinson's Disease
Klingelhoefer, L., & Reichmann, H. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.027 · Cited by 53
Self-citationJellinger, K. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02028-6 · Cited by 58
The nonmotor features of Parkinson's disease: pathophysiology and management advances
Reichmann, H., Brandt, M., & Klingelhoefer, L. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000348 · Cited by 53
Self-citationPeña‐Díaz, S., García‐Pardo, J., & Ventura, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030839 · Cited by 54
Isolation of high-purity myenteric plexus from adult human and mouse gastrointestinal tract
Grundmann, D., Klotz, M., Rabe, H., Glanemann, M., & Schäfer, K. (2015) · Scientific Reports · doi:10.1038/srep09226 · Cited by 54
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
Perez‐Pardo, P., Hartog, M., Garssen, J., & Kraneveld, A. D. (2017) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-017-0129-2 · Cited by 53
Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology
Pan-Montojo, F. J., & Reichmann, H. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-10 · Cited by 54
Self-citationCombined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease
Liu, H., Ho, P. W., Leung, G. C.-T., Lam, C. S.-C., Pang, S. Y.-Y., Li, L., Kung, M. H.-W., Ramsden, D. B., & Ho, S. (2017) · Scientific Reports · doi:10.1038/srep40887 · Cited by 55
Gastrointestinal disorders in Parkinson’s disease and other Lewy body diseases
Hirayama, M., Nishiwaki, H., Hamaguchi, T., & Ohno, K. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00511-2 · Cited by 51
New insights in animal models of neurotoxicity-induced neurodegeneration
Sanfeliu, C., Bartra, C., Sunol, C. E., & Rodrı́guez-Farré, E. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1248727 · Cited by 54
Toti, L., & Travagli, R. A. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00258.2014 · Cited by 52
Torraco, A., Peralta, S., Iommarini, L., & Díaz, F. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.01.009 · Cited by 50
Parkinson mice show functional and molecular changes in the gut long before motoric disease onset
Gries, M., Christmann, A., Schulte, S., Weyland, M., Rommel, S., Martin, M., Baller, M. K., Röth, R., Schmitteckert, S., Unger, M. M., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00439-2 · Cited by 55
Choi, W., Kim, H.-W., Tronche, F., Palmiter, R. D., Storm, D. R., & Xia, Z. (2017) · Scientific Reports · doi:10.1038/srep44989 · Cited by 49
Ko, W. K. D., & Bézard, E. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.020 · Cited by 48
Baicalein Protects against Rotenone-Induced Neurotoxicity through Induction of Autophagy
Kuang, L., Cao, X., & Lu, Z. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00392 · Cited by 49
Gupta, R. C., Mukherjee, I. R. M., Malik, J. K., Doss, R. B., Dettbarn, W., & Milatović, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814655-2.00026-8 · Cited by 47
α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges
Arias-Carrión, Ó., Guerra‐Crespo, M., Padilla-Godínez, F. J., Soto-Rojas, L. O., & Manjarrez, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115405 · Cited by 51
Alpha Synuclein in Parkinson’s Disease
Kragh, C. L., Romero‐Ramos, M., Halliday, G. M., & Jensen, P. H. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_14 · Cited by 48
What Is the Evidence that Parkinson’s Disease Is a Prion Disorder, Which Originates in the Gut?
Kujawska, M., & Jodynis‐Liebert, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113573 · Cited by 48
Rotenone neurotoxicity: Relevance to Parkinson's disease
Lawana, V., & Cannon, J. R. (2020) · Advances in neurotoxicology · doi:10.1016/bs.ant.2019.11.004 · Cited by 48
Autonomic dysfunction in Parkinson disease and animal models
Metzger, J. M., & Emborg, M. E. (2019) · Clinical Autonomic Research · doi:10.1007/s10286-018-00584-7 · Cited by 46
Environmental triggers of Parkinson's disease – Implications of the Braak and dual-hit hypotheses
Chen, H., Wang, K., Scheperjans, F., & Killinger, B. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105601 · Cited by 45
Pradhan, S., & Andreasson, K. I. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.12.008 · Cited by 43
The Presence of Alpha‐Synuclein in Skin from Melanoma and Patients with Parkinson's Disease
Rodríguez‐Leyva, I., Chi-Ahumada, É., Mejía, M., Castanedo-Cázares, J. P., Eng, W., Saikaly, S. K., Carrizales-Rodríguez, J., Levine, T., Norman, R. A., & Jiménez-Capdeville, M. E. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12494 · Cited by 43
The Rotenone Models Reproducing Central and Peripheral Features of Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2020) · NeuroSci · doi:10.3390/neurosci1010001 · Cited by 44
Metadata
- Authors
- Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M. G., Reichmann, H., & Funk, R. H. W.
- Affiliations
- Max Planck Institute of Molecular Cell Biology and Genetics (DE)
- University of Cambridge (GB)
- Technische Universität Dresden (DE)
- Corresponding author
- Pan-Montojo, Francisco
- Funk, Richard H. W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-01-19
- Volume
- 5
- Issue
- 1
- Pages
- e8762
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2808242
- OpenAlex
- W2293877091
- Cited by
- 524
- References
- 64
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 18 · 2023: 28 · 2022: 40 · 2021: 43 · 2020: 41 · 2019: 46 · 2018: 31 · 2017: 44 · 2016: 35 · 2015: 32 · 2014: 33 · 2013: 29 · 2012: 37
- FWCI
- 18.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Parkinson's UK (G-0701)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, rotenone, intragastric administration, alpha-synuclein accumulation, enteric nervous system, dorsal motor nucleus of the vagus, intermediolateral nucleus, substantia nigra, mitochondrial complex I inhibition, neuroinflammation, alpha-synuclein phosphorylation, pesticide exposure, disease staging, motor impairment, mouse model
- MeSH terms
- Animals, Chromatography, High Pressure Liquid, Disease Models, Animal, Mice, Inbred BALB C, Parkinson Disease, Rotenone, Stomach, Enteric Nervous System, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
